Clinical Trial Update: A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

View source ↗

Summary

A real-world study evaluating the safety and effectiveness of secukinumab in pediatric patients with plaque psoriasis in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Status: COMPLETED